Change in Director / Key Managerial Personnel
Nature of Changes: The company has implemented internal organizational changes affecting four senior management personnel, comprising three role changes and one new appointment, all effective from July 1, 2026.
Detailed Changes:
- Mr. Abhijit Roy: Role change from "Marketing Strategy and Planning leader, E-commerce & Commercial Excellence Leader" to "Sales Leader (South and East region) and Exports Leader"
- Mr. M. Padmakar Rao: Role change from "Sales Leader (West and South region)" to "Sales Leader (North & West region) and Institutional Business Leader"
- Mr. Nilesh Barbade: Role change from "Sales Leader (North and East region)" to "Sales Leader (Trade)"
- Mr. Shine Matthew Sunny: Appointment to "Marketing Strategy and Planning leader, Commercial Excellence & E-commerce Leader" (previously not in senior management)
Individual Profiles and Qualifications:
- Mr. Abhijit Roy: Over 30 years of Pharma/OTC experience, including 22 years at Merck India and P&G Health. Science graduate from Guwahati University. Career progression from Medical Representative to Director of Sales with expertise in Market Strategy & Planning, Digital Commerce, and Sales Force Automation.
- Mr. M. Padmakar Rao: Bachelor of Science from Osmania University, Hyderabad and Post Graduate Diploma in Pharmaceutical Business Management from MET Institute of Management, Mumbai. Over 25 years of pharmaceutical industry experience with expertise in field sales, marketing operations, trade channel management, and commercial excellence.
- Mr. Nilesh Barbade: Masters in Business Administration from UAS, Dharwad and Bachelor of Science degree. Over 26 years of pharmaceutical industry experience with expertise in pharma, OTC and food categories. Previously served as Director of Sales, Institutional Business Leader, Distributor operations and Export leader.
- Mr. Shine Matthew Sunny: Postgraduate Diploma in Management from IMIS, Bhubaneswar and Bachelor of Commerce from St. Xavier's College, Calcutta University. Over 15 years of experience with P&G and Reckitt Benckiser group. Expertise in sales strategy, commercial excellence, category strategy, corporate strategy, e-commerce, and business transformation.
Continuity Statement: The disclosure specifically notes that these are "internal organizational changes" and all individuals "shall continue to be part of the Senior Management Personnel of the Company."
Regulatory Compliance: The disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirement) Regulations, 2015.
Company Details:
- Scrip Symbol / Code: 500126 (BSE), PGHL (NSE)
- Date: June 25, 2026